DE1545760C3 - Vincaleukoblastinderivate - Google Patents

Vincaleukoblastinderivate

Info

Publication number
DE1545760C3
DE1545760C3 DE1545760A DEE0028828A DE1545760C3 DE 1545760 C3 DE1545760 C3 DE 1545760C3 DE 1545760 A DE1545760 A DE 1545760A DE E0028828 A DEE0028828 A DE E0028828A DE 1545760 C3 DE1545760 C3 DE 1545760C3
Authority
DE
Germany
Prior art keywords
residue
dissolved
vincaleukoblastin
evaporation
mixture
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE1545760A
Other languages
German (de)
English (en)
Other versions
DE1545760A1 (de
DE1545760B2 (de
Inventor
William Walter Indianapolis Ind. Hargrove (V.St.A.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of DE1545760A1 publication Critical patent/DE1545760A1/de
Publication of DE1545760B2 publication Critical patent/DE1545760B2/de
Application granted granted Critical
Publication of DE1545760C3 publication Critical patent/DE1545760C3/de
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00
    • C07D519/04—Dimeric indole alkaloids, e.g. vincaleucoblastine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Indole Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE1545760A 1964-03-09 1965-03-08 Vincaleukoblastinderivate Expired DE1545760C3 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US350519A US3392173A (en) 1964-03-09 1964-03-09 Novel acyl derivatives of desacetyl-vincaleukoblastine and processes for their preparation

Publications (3)

Publication Number Publication Date
DE1545760A1 DE1545760A1 (de) 1969-11-27
DE1545760B2 DE1545760B2 (de) 1978-02-09
DE1545760C3 true DE1545760C3 (de) 1978-10-05

Family

ID=23377073

Family Applications (3)

Application Number Title Priority Date Filing Date
DE1795823A Expired DE1795823C3 (de) 1964-03-09 1965-03-08 Desacetylvincaleukoblastin und seine Salze mit Säuren
DE1545760A Expired DE1545760C3 (de) 1964-03-09 1965-03-08 Vincaleukoblastinderivate
DE1795763A Expired DE1795763C3 (de) 1964-03-09 1965-03-08 Verfahren zur Herstellung von Vincaleukoblastin- und Leurocristinderivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE1795823A Expired DE1795823C3 (de) 1964-03-09 1965-03-08 Desacetylvincaleukoblastin und seine Salze mit Säuren

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE1795763A Expired DE1795763C3 (de) 1964-03-09 1965-03-08 Verfahren zur Herstellung von Vincaleukoblastin- und Leurocristinderivaten

Country Status (9)

Country Link
US (1) US3392173A (US07345094-20080318-C00003.png)
BE (1) BE660843A (US07345094-20080318-C00003.png)
CH (1) CH507970A (US07345094-20080318-C00003.png)
DE (3) DE1795823C3 (US07345094-20080318-C00003.png)
ES (1) ES310240A1 (US07345094-20080318-C00003.png)
FR (2) FR1449628A (US07345094-20080318-C00003.png)
GB (1) GB1095833A (US07345094-20080318-C00003.png)
NL (1) NL6502977A (US07345094-20080318-C00003.png)
SE (1) SE330700B (US07345094-20080318-C00003.png)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3899493A (en) * 1972-12-29 1975-08-12 Richter Gedeon Vegyeszet Chromic acid oxidation of vinblastine sulfate to form vincristine
HU165986B (US07345094-20080318-C00003.png) * 1973-02-16 1974-12-28
US4012390A (en) * 1974-10-16 1977-03-15 Eli Lilly And Company Vinblastinoic acid
US3954773A (en) * 1974-11-21 1976-05-04 Eli Lilly And Company 4-Desacetoxyvinblastine
US3944554A (en) * 1975-01-09 1976-03-16 Eli Lilly And Company 4-Desacetoxy-3-hydroxyvinblastine
US4029663A (en) * 1975-07-10 1977-06-14 Eli Lilly And Company Dimeric anhydro-vinca derivatives
US4209443A (en) * 1976-02-13 1980-06-24 Richter Gedeon Vegyeszeti Gyar Rt. Process for separating pharmaceutically active diindole alkaloids
US4143041A (en) * 1977-01-19 1979-03-06 Eli Lilly And Company 4'-Deoxyvincristine and related compounds
HU178084B (en) * 1977-05-31 1982-03-28 Richter Gedeon Vegyeszet New process for the extraction of native vindoline,catharantine,3',4'-anhydrovinblastine,leurosine and,if desired,of other diinodle alkaloids from vinca rosea l.drogue
US4195022A (en) * 1978-03-27 1980-03-25 Eli Lilly And Company 4-Desacetoxy-4α-hydroxyvinblastine and related compounds
US4166810A (en) * 1978-04-20 1979-09-04 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxyhydrazide
HU178706B (en) * 1979-04-23 1982-06-28 Richter Gedeon Vegyeszet Process for preparing bis-indole alkaloids and acid addition salts thereof
FR2461714A1 (fr) 1979-07-17 1981-02-06 Anvar Nouvelle classe de composes bis-indoliques utiles comme medicaments et procede pour leur preparation
GR79898B (US07345094-20080318-C00003.png) * 1983-03-30 1984-10-31 Lilly Industries Ltd
US4522750A (en) * 1984-02-21 1985-06-11 Eli Lilly And Company Cytotoxic compositions of transferrin coupled to vinca alkaloids
HU198074B (en) * 1985-06-12 1989-07-28 Richter Gedeon Vegyeszet Process for producing new bis-indole derivatives and pharmaceutical compositions comprising these compounds
HU193318B (en) * 1985-06-12 1987-09-28 Richter Gedeon Vegyeszet Process for producing new bis- indol derivatives
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
HUT76925A (hu) * 1995-04-04 1998-01-28 MTA Enzimológiai Intézet Bisz-indol-származékok, eljárás előállításukra és az azokat tartalmazó gyógyszerkészítmények
US6326402B1 (en) 1998-08-12 2001-12-04 Octamer, Inc. Methods for treating viral infections using a compound capable of inhibiting microtubules
ATE427948T1 (de) * 2001-04-24 2009-04-15 Purdue Research Foundation Folat-mimetika und deren folatrezeptorbindende konjugate
ES2324708T3 (es) * 2002-05-15 2009-08-13 Endocyte, Inc. Conjugados de vitamina-mitomicina.
US7601332B2 (en) 2003-01-27 2009-10-13 Endocyte, Inc. Vitamin receptor binding drug delivery conjugates
EP1789391B1 (en) 2004-07-23 2017-06-28 Endocyte, Inc. Bivalent linkers and conjugates thereof
EP1863816B1 (en) * 2005-03-16 2014-06-25 Endocyte, Inc. Synthesis and purification of pteroic acid and conjugates thereof
EP1948241B1 (en) * 2005-08-19 2014-03-05 Endocyte, Inc. Multi-drug ligand conjugates
WO2007022493A2 (en) 2005-08-19 2007-02-22 Endocyte, Inc. Ligand conjugates of vinca alkaloids, analogs, and derivatives
US20100104626A1 (en) * 2007-02-16 2010-04-29 Endocyte, Inc. Methods and compositions for treating and diagnosing kidney disease
AU2008224988A1 (en) * 2007-03-14 2008-09-18 Endocyte, Inc. Binding ligand linked drug delivery conjugates of tubulysins
US9138484B2 (en) 2007-06-25 2015-09-22 Endocyte, Inc. Conjugates containing hydrophilic spacer linkers
US9877965B2 (en) 2007-06-25 2018-01-30 Endocyte, Inc. Vitamin receptor drug delivery conjugates for treating inflammation
CA2703491C (en) * 2007-10-25 2017-06-13 Endocyte, Inc. Tubulysins and processes for preparing
WO2013126797A1 (en) 2012-02-24 2013-08-29 Purdue Research Foundation Cholecystokinin b receptor targeting for imaging and therapy
US20140080175A1 (en) 2012-03-29 2014-03-20 Endocyte, Inc. Processes for preparing tubulysin derivatives and conjugates thereof
SG11201502896XA (en) 2012-10-16 2015-05-28 Endocyte Inc Drug delivery conjugates containing unnatural amino acids and methods for using

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097137A (en) * 1960-05-19 1963-07-09 Canadian Patents Dev Vincaleukoblastine
US3169968A (en) * 1962-05-08 1965-02-16 Ciba Geigy Corp Esters of ajmaline and related compounds
US3225053A (en) * 1963-01-10 1965-12-21 Lilly Co Eli Quebrachidine and derivatives

Also Published As

Publication number Publication date
DE1545760A1 (de) 1969-11-27
DE1795823B2 (de) 1981-04-30
US3392173A (en) 1968-07-09
CH507970A (de) 1971-05-31
DE1795763C3 (de) 1978-06-29
NL6502977A (US07345094-20080318-C00003.png) 1965-09-10
BE660843A (US07345094-20080318-C00003.png) 1965-09-09
DE1795823A1 (de) 1976-02-05
ES310240A1 (es) 1965-10-16
SE330700B (US07345094-20080318-C00003.png) 1970-11-30
DE1545760B2 (de) 1978-02-09
FR6668M (US07345094-20080318-C00003.png) 1969-02-03
DE1795823C3 (de) 1982-04-15
DE1795763A1 (de) 1974-11-21
GB1095833A (en) 1967-12-20
FR1449628A (fr) 1966-08-19
DE1795763B2 (de) 1977-11-10

Similar Documents

Publication Publication Date Title
DE1545760C3 (de) Vincaleukoblastinderivate
DE1643296C3 (de) l-Aryl-2-alkylaminoäthanole und deren physiologisch verträgliche Säureadditionssalze, Verfahren zu deren Herstellung und sie enthaltende Arzneimittel
DE2025624C2 (de) 5'-0-Ester von ara-Cytidin und Verfahren zu ihrer Herstellung
DE2515629A1 (de) Paromomycin-derivate, verfahren zu ihrer herstellung und arzneimittel
DE1811518C3 (de) Daunonibicinderivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
DE2066118C3 (de) 14-Desoxy-14-tosyloxyacetoxymutilin und Verfahr en zu dessen Herstellung
DE1958514C3 (de) Apovincaminsaureamid
DE2614946C2 (de) Neue Nucleosidderivate
DE1493618A1 (de) Cumarinderivate und ein Verfahren zu ihrer Herstellung
DE2005959A1 (de) 7-Nitro-8-hydroxychinolinester, ihre Verwendung und Verfahren zur Herstellung derselben
DE2727629A1 (de) 1-p-chlorbenzoyl-5-methoxy-2-methyl- 3-indolyl-essigsaeure-2'-phenyl-2'-carbonsaeureaethylester, verfahren zu seiner herstellung und pharmazeutische mittel
DE1470196C (de) 1 Hydroxymethyl colchicindenvate und Verfahren zu ihrer Herstellung
CH449006A (de) Verfahren zur Herstellung von Fusidinsäure- und Dihydrofusidinsäurederivaten
DE3102984A1 (de) Verfahren zur herstellung von cysteamin-s-substituierten verbindungen und deren derivaten
DE1695580C (de) Quaternare Verbindungen des Benzil saure beta piperidino athylesters und ein Verfahren zu ihrer Herstellung
DE2549733C2 (de) 1,3-Bis-(β-aethylhexyl)-5-amino-5-methyl-hexahydropyrimidin-terephthalat, Verfahren zu seiner Herstellung und dieses enthaltende Arzneimittel
AT241707B (de) Verfahren zur Herstellung neuer Oestradiolderivate
DE1244761B (de) Verfahren zur Herstellung von substituierten Benzoesaeureamiden
AT203491B (de) Verfahren zur Herstellung von neuen 3,5-Diketo-pyrazolidin-Derivaten
AT226380B (de) Verfahren zur Herstellung von Lysergsäurehydraziden
AT266120B (de) Verfahren zur Herstellung von neuen Diazahydrindan- und Pyridopyrimidinderivaten und ihren Salzen
DE948158C (de) Verfahren zur Herstellung von Zink-Komplexsalzen von Tripeptiden
AT229865B (de) Verfahren zur Herstellung von neuen N-Carbäthoxy-aminosäure-(5-nitrofurfuryliden)-hydraziden
AT210886B (de) Verfahren zur Herstellung von neuen, basisch substituierten Diphenylcarbinolestern und deren Salzen
DE2264641A1 (de) 5-brom-2,2'-cyclocytidin-3',5'-diacylate

Legal Events

Date Code Title Description
C3 Grant after two publication steps (3rd publication)
AH Division in

Ref country code: DE

Ref document number: 1795823

Format of ref document f/p: P

8339 Ceased/non-payment of the annual fee